NCT06659536View on ClinicalTrials.gov

Cefar URO - Symptomatic Treatment of Overactive Bladder

NANot yet recruitingINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Overactive Bladder (OAB)Refractory Overactive BladderUrinary Urgency and Frequency
Interventions
DEVICE

Transcutaneous Tibial Nerve Stimulation (TTNS) with the Cefar Uro Device

Transcutaneous Tibial Nerve Stimulation (TTNS) with the Cefar URO device using the preset program P4 (parameter setting: frequency 20Hz, pulse width 200μs) for the symptomatic treatment of urge incontinence in adults with overactive bladder in accordance with the approved labelling.

Trial Locations (1)

75020

Neuro-Urology Department, Tenon Hospital, Paris

All Listed Sponsors
lead

DJO UK Ltd

INDUSTRY

NCT06659536 - Cefar URO - Symptomatic Treatment of Overactive Bladder | Biotech Hunter | Biotech Hunter